Preclinical results have found that patients with pancreatic cancer may benefit from an investigational member of an emerging class of anticancer drugs called antibody-drug conjugates. The results were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23. Antibody-drug conjugates are a new type of targeted anticancer therapy, which use an antibody to deliver an attached drug directly to those cells ...You have just read an article categorized health
titled New Treatment Option for Pancreatic Cancer Patients Could Be Aided By Antibody-drug Conjugate.
Written by:
editor - Sunday, October 27, 2013
There are currently no comments for "New Treatment Option for Pancreatic Cancer Patients Could Be Aided By Antibody-drug Conjugate"
Post a Comment